Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
Top Cited Papers
- 1 July 2009
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 7 (s1) , 332-339
- https://doi.org/10.1111/j.1538-7836.2009.03404.x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritisArthritis Care & Research, 2008
- Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyArthritis Research & Therapy, 2008
- Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward ConsensusPublished by Elsevier ,2007
- Patterns of cardiovascular risk in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic MechanismsNature Reviews Drug Discovery, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenNew England Journal of Medicine, 2004
- Inflammation in atherosclerosisNature, 2002